HomeInsights52 Week Low Stocks

Shilpa Medicare Ltd 52 Week Low

Shilpa Medicare Ltd 52 Week Low

stocks purchased

₹ 0.8 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

10.1 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 27, 2024

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

YEARLOW

₹ 313.55

Last updated on: Dec 26, 2024

Key Highlights

  • The 52 Week Low of Shilpa Medicare Ltd is ₹ 313.55 as of 26 Dec 24 .

Company Fundamentals for Shilpa Medicare Ltd

No data available

Market Price of Shilpa Medicare Ltd

1M

1Y

3Y

5Y

Monitoring Shilpa Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 2024764.75
24 Dec 2024765.95
23 Dec 2024778
20 Dec 2024814.4
19 Dec 2024829
18 Dec 2024830.55
17 Dec 2024822.45
16 Dec 2024810.65
13 Dec 2024816
12 Dec 2024819.4

Asset Value vs Market Value of Shilpa Medicare Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Shilpa Medicare Ltd

No data available

* All values are in crore

Shilpa Medicare Ltd News Hub

News

Shilpa Medicare's Unit IV and Unit VII secures Eurasia GMP approval

Shilpa Medicare, Unit IV, Jadcherla, Telangana, India and Shilpa Medicare, Unit VII, Nacha...

Read more

27 Dec 2024 11:36

News

Shilpa Medicare gets GMP approval for Hyderabad facilities

Both units of Shilpa Medicare's (Unit IV and Unit VII) have now received GMP approval of E...

Read more

27 Dec 2024 12:19

News

Shilpa Medicare gets GMP certification for Hyderabad Facility

The inspection was conducted from 24 September 2024 to 26 September 2024. On conclusion of...

Read more

20 Dec 2024 15:14

News

Shilpa Medicare JV gets USFDA approval for IMKELDI drug

Oncosol is 50:50 joint venture between Liqmeds Lifecare, a Zydus Group company, and Koana ...

Read more

27 Nov 2024 15:47

News

Shilpa Medicare gets nod for Phase III clinical trials of Human Albumin

Albumin is in high demand for various medical treatments, including restoring blood volume...

Read more

26 Nov 2024 15:00

News

Shilpa Medicare spurts on European regulator nod for Octreotide & Nifedipine

Octreotide, a synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid-p...

Read more

19 Nov 2024 11:24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Shilpa Medicare Ltd

Why is it important to track the 52-week low of Shilpa Medicare Ltd stocks?

Investors should monitor the 52-week low of Shilpa Medicare Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Shilpa Medicare Ltd stocks hitting a 52-week low?

Factors leading to Shilpa Medicare Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Shilpa Medicare Ltd stocks when they hit a 52-week low?

Buying Shilpa Medicare Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Shilpa Medicare Ltd stocks?

Investors should monitor the 52-week low of Shilpa Medicare Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Shilpa Medicare Ltd stock at their 52-week low?

An investor can analyze the reasons for the Shilpa Medicare Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Shilpa Medicare Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Shilpa Medicare Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Shilpa Medicare Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions